Cubist Systematic Strategies’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-36,762
Closed -$15.1M 3298
2024
Q2
$15.1M Sell
36,762
-31,004
-46% -$12.3M 0.1% 233
2024
Q1
$27.4M Buy
67,766
+17,731
+35% +$6.23M 0.16% 107
2023
Q4
$15.3M Sell
50,035
-2,483
-5% -$670K 0.1% 238
2023
Q3
$12.7M Sell
52,518
-62,084
-54% -$15.9M 0.09% 274
2023
Q2
$27.5M Buy
114,602
+22,502
+24% +$4.67M 0.18% 78
2023
Q1
$17.3M Buy
92,100
+2,623
+3% +$542K 0.11% 200
2022
Q4
$19M Buy
89,477
+54,271
+154% +$10.8M 0.11% 170
2022
Q3
$5.53M Sell
35,206
-12,676
-26% -$2.02M 0.03% 986
2022
Q2
$7.17M Buy
47,882
+33,171
+225% +$4.8M 0.04% 670
2022
Q1
$2.41M Sell
14,711
-7,682
-34% -$1.27M 0.02% 1327
2021
Q4
$4.87M Buy
22,393
+6,813
+44% +$1.43M 0.05% 670
2021
Q3
$2.95M Sell
15,580
-12
-0.1% -$2.19K 0.04% 766
2021
Q2
$2.75M Buy
15,592
+1,790
+13% +$309K 0.03% 886
2021
Q1
$2.26M Buy
13,802
+1,701
+14% +$260K 0.03% 941
2020
Q4
$1.68M Sell
12,101
-23,136
-66% -$2.92M 0.02% 1063
2020
Q3
$3.94M Buy
35,237
+22,034
+167% +$2.55M 0.06% 528
2020
Q2
$1.23M Buy
13,203
+5,317
+67% +$452K 0.02% 1066
2020
Q1
$579K Sell
7,886
-955
-11% -$82.9K 0.02% 1161
2019
Q4
$743K Sell
8,841
-5,958
-40% -$461K 0.01% 1340
2019
Q3
$1.24M Buy
+14,799
New +$1.12M 0.02% 874
2019
Q2
Sell
-3,611
Closed -$213K 2530
2019
Q1
$213K Buy
+3,611
New +$216K 0.01% 1734
2018
Q4
Sell
-10,760
Closed -$645K 2190
2018
Q3
$645K Buy
10,760
+5,459
+103% +$299K 0.04% 681
2018
Q2
$228K Buy
+5,301
New +$214K 0.01% 1258
2017
Q1
Sell
-6,304
Closed -$227K 1750
2016
Q4
$227K Buy
+6,304
New +$210K 0.02% 1172

Other funds holding MEDP

Cubist Systematic Strategies's MEDP Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Medpace (MEDP) in Q3 2024, closing a stake of 36,762 shares — an estimated $15.1M sold.

Cubist Systematic Strategies first reported a position in MEDP in Q4 2016 and held it in 24 quarters. The position peaked at $27.5M in Q2 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 36,762 Medpace shares in Q3 2024, an estimated $15.1M.
  • Cubist Systematic Strategies first reported a position in Medpace in Q4 2016 and held it in 24 quarters.
  • Cubist Systematic Strategies's Medpace position peaked at $27.5M in Q2 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.